Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels

Published: 2025-05-22 10:38:31 ET EOLS

Published on 05/22/2025 at 10:38

Evolus, Inc. announced the publication of the U.S. pivotal study results for Evolysse Form and Evolysse Smooth in the Aesthetic Surgery Journal, a leading peer-reviewed journal focusing on advances in aesthetic medicine and surgery. The multicenter, randomized, controlled, double-blind study followed 140 patients through 12 months and evaluated the long-term safety and effectiveness of Evolysse?? Form and Evolysse??

Smooth, Cold-X?? crosslinked injectable hyaluronic acid (HA) gels, for the correction of moderate to severe dynamic facial wrinkles and folds. Key published findings include: Statistical Superiority: Evolysse??

form and Evolysse?, the.